New sleep program aims to help Alzheimer's patients and caregivers rest better

NCT ID NCT05452031

Recruiting now Symptom relief Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a behavioral sleep program called Care2Sleep for people with Alzheimer's disease and their caregivers. The program includes sleep hygiene, activity, and light exposure. Researchers will compare it to a sleep education group to see if it improves sleep, health, and quality of life. The trial involves 672 participants and will be delivered in person or via telehealth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Care2Sleep behavioral sleep program
What this could lead to: If it works, this could provide a practical, non-drug way to improve sleep and well-being for both Alzheimer's patients and their caregivers.
What could go wrong: This is a behavioral intervention study, not a drug trial, so benefits may be modest. Results depend on adherence and may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SLEEP

Contacts and locations

Locations

University of California Los Angeles
RECRUITING

Los Angeles, California, 90095, United States
University of California San Diego
RECRUITING

La Jolla, California, 92093, United States
Veterans Affairs Greater Los Angeles Healthcare System
RECRUITING

Los Angeles, California, 91343, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.